Daniel Plaksin

645 total citations
23 papers, 544 citations indexed

About

Daniel Plaksin is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Plaksin has authored 23 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Plaksin's work include Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and T-cell and B-cell Immunology (7 papers). Daniel Plaksin is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and T-cell and B-cell Immunology (7 papers). Daniel Plaksin collaborates with scholars based in Israel, United States and Denmark. Daniel Plaksin's co-authors include Lea Eisenbach, Patrick A. Baeuerle, David H. Margulies, Michael B. Feldman, Yoram Reiter, Cohava Gelber, Lisa F. Boyd, Peter Schuck, K Poláková and P McPhie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Daniel Plaksin

21 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Plaksin Israel 14 347 203 160 127 82 23 544
G. Nagel Germany 11 276 0.8× 173 0.9× 171 1.1× 138 1.1× 22 0.3× 13 597
K. Jurianz Germany 8 312 0.9× 130 0.6× 103 0.6× 81 0.6× 30 0.4× 10 469
Christian K. Behrens Germany 11 299 0.9× 240 1.2× 193 1.2× 111 0.9× 21 0.3× 13 553
Hilary Vaughan Australia 16 527 1.5× 404 2.0× 152 0.9× 178 1.4× 20 0.2× 24 926
Ruth A. Salmon Canada 7 180 0.5× 230 1.1× 69 0.4× 205 1.6× 47 0.6× 15 473
Sabrina Sforzini Italy 12 396 1.1× 170 0.8× 66 0.4× 169 1.3× 24 0.3× 18 649
B E Rich United States 8 272 0.8× 260 1.3× 39 0.2× 109 0.9× 22 0.3× 9 629
Daniel Laune France 10 70 0.2× 184 0.9× 112 0.7× 95 0.7× 20 0.2× 14 382
Errin Lagow United States 7 161 0.5× 210 1.0× 64 0.4× 50 0.4× 26 0.3× 9 399
Jonathan Stevens United States 8 650 1.9× 536 2.6× 177 1.1× 455 3.6× 99 1.2× 13 1.0k

Countries citing papers authored by Daniel Plaksin

Since Specialization
Citations

This map shows the geographic impact of Daniel Plaksin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Plaksin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Plaksin more than expected).

Fields of papers citing papers by Daniel Plaksin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Plaksin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Plaksin. The network helps show where Daniel Plaksin may publish in the future.

Co-authorship network of co-authors of Daniel Plaksin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Plaksin. A scholar is included among the top collaborators of Daniel Plaksin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Plaksin. Daniel Plaksin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bjerregaard, Simon, et al.. (2022). Co-formulations of adalimumab with hyaluronic acid/polyvinylpyrrolidone to combine intraarticular drug delivery and viscosupplementation. European Journal of Pharmaceutics and Biopharmaceutics. 177. 39–49. 4 indexed citations
3.
Plaksin, Daniel, et al.. (2017). Comparative pharmacology of a new recombinant FSH expressed by a human cell line. Endocrine Connections. 6(5). 297–305. 32 indexed citations
4.
Feldman, M., et al.. (2007). The Reversal of the Metastatic Phenotype by Gene Transfer. Novartis Foundation symposium. 141. 170–192.
5.
Plaksin, Daniel, et al.. (2003). Single-Domain V<sub>H</sub> Antibody Fragments from a Phage Display Library. Humana Press eBooks. 207. 133–144. 2 indexed citations
6.
Poláková, K, Daniel Plaksin, Doo Hyun Chung, et al.. (2000). Antibodies Directed Against the MHC-I Molecule H-2Dd Complexed with an Antigenic Peptide: Similarities to a T Cell Receptor with the Same Specificity. The Journal of Immunology. 165(10). 5703–5712. 27 indexed citations
7.
Chung, Doo Hyun, Jeffrey R. Dorfman, Daniel Plaksin, et al.. (1999). NK and CTL Recognition of a Single Chain H-2Dd Molecule: Distinct Sites of H-2Dd Interact with NK and TCR. The Journal of Immunology. 163(7). 3699–3708. 23 indexed citations
8.
Reiter, Yoram, Peter Schuck, Lisa F. Boyd, & Daniel Plaksin. (1999). An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface 1 1Edited by I. A. Wilson. Journal of Molecular Biology. 290(3). 685–698. 69 indexed citations
9.
Plaksin, Daniel, Susan Chacko, Jorge Navaza, David H. Margulies, & Eduardo A. Padlan. (1999). The X-ray crystal structure of a Vα2.6Jα38 mouse T cell receptor domain at 2.5 å resolution: alternate modes of dimerization and crystal packing a 1Edited by I. A. Wilson. Journal of Molecular Biology. 289(5). 1153–1161. 13 indexed citations
10.
Plaksin, Daniel, K Poláková, Michael G. Mage, & David H. Margulies. (1997). Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation. The Journal of Immunology. 159(9). 4408–4414. 5 indexed citations
11.
Plaksin, Daniel, K Poláková, P McPhie, & David H. Margulies. (1997). A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes. The Journal of Immunology. 158(5). 2218–2227. 43 indexed citations
12.
Margulies, David H., et al.. (1996). Studying interactions involving the T-cell antigen receptor by surface plasmon resonance. Current Opinion in Immunology. 8(2). 262–270. 35 indexed citations
13.
Plaksin, Daniel, Susan Chacko, P McPhie, et al.. (1996). A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution?. The Journal of Experimental Medicine. 184(4). 1251–1258. 13 indexed citations
14.
Plaksin, Daniel, Angel Porgador, Ezra Vadai, et al.. (1994). Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV). International Journal of Cancer. 59(6). 796–801. 32 indexed citations
15.
Plaksin, Daniel, Patrick A. Baeuerle, & Lea Eisenbach. (1993). KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.. The Journal of Experimental Medicine. 177(6). 1651–1662. 110 indexed citations
16.
17.
Plaksin, Daniel, et al.. (1989). Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.. PubMed. 49(9). 2366–73. 17 indexed citations
18.
Feldman, M., et al.. (1988). Control of MHC Genes that Regulate the Metastatic Phenotype of Tumor Cells. Advances in experimental medicine and biology. 233. 109–117. 6 indexed citations
19.
Plaksin, Daniel, Cohava Gelber, Michael B. Feldman, & Lea Eisenbach. (1988). Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.. Proceedings of the National Academy of Sciences. 85(12). 4463–4467. 71 indexed citations
20.
Plaksin, Daniel, et al.. (1987). Expression of major histocompatibility class I genes in differentiating leukemic cells is temporally related to activation of c-fos proto-oncogene.. PubMed. 1(3). 198–204. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Nagel Breakdown of academic impact, for papers by K. Jurianz Breakdown of academic impact, for papers by Christian K. Behrens Breakdown of academic impact, for papers by Hilary Vaughan Breakdown of academic impact, for papers by Ruth A. Salmon Breakdown of academic impact, for papers by Sabrina Sforzini Breakdown of academic impact, for papers by B E Rich Breakdown of academic impact, for papers by Daniel Laune Breakdown of academic impact, for papers by Errin Lagow Breakdown of academic impact, for papers by Jonathan Stevens
Rankless by CCL
2026